Stockscreener 앱 받기
0.623
7.45%
0.0432
시간 외 거래:
.62
-0.00299
-0.48%
전일 마감가:
$0.5798
열려 있는:
$0.613
하루 거래량:
451.79K
Relative Volume:
1.80
시가총액:
$N/A
수익:
$80.72M
순이익/손실:
$-56.64M
주가수익비율:
-2.492
EPS:
-0.25
순현금흐름:
$-37.17M
1주 성능:
-4.91%
1개월 성능:
+71.15%
6개월 성능:
+55.75%
1년 성능:
-35.85%
1일 변동 폭
$0.575
$0.65
1주일 범위
$0.521
$0.65
52주 변동 폭
$0.33
$0.7117
Vaxart Inc Stock (VXRT) Company Profile
Compare VXRT vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
VXRT
Vaxart Inc
|
0.623 | 0 | 80.72M | -56.64M | -37.17M | -0.25 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.81 | 119.38B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
766.63 | 81.46B | 14.34B | 4.50B | 3.88B | 41.57 |
|
ARGX
Argen X Se Adr
|
820.31 | 52.65B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
331.24 | 46.50B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
347.00 | 38.95B | 4.98B | 69.60M | 525.67M | 0.5198 |
Vaxart Inc Stock (VXRT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-08-15 | 개시 | Oppenheimer | Outperform |
| 2021-12-29 | 재개 | Jefferies | Buy |
| 2021-11-02 | 개시 | Cantor Fitzgerald | Overweight |
| 2021-06-29 | 다운그레이드 | B. Riley Securities | Buy → Neutral |
| 2021-06-24 | 개시 | Jefferies | Buy |
| 2021-06-11 | 개시 | Piper Sandler | Overweight |
| 2020-08-12 | 재확인 | H.C. Wainwright | Buy |
| 2020-07-13 | 개시 | B. Riley FBR | Buy |
모두보기
Vaxart Inc 주식(VXRT)의 최신 뉴스
Is Vaxart Inc.’s ROE strong enoughMarket Sentiment Review & High Yield Equity Trading Tips - Mfd.ru
Vaxart (VXRT) Valuation After New npj Vaccines Data On Oral Norovirus Candidate In Breastfeeding Women - Yahoo Finance
Does Vaxart’s (VXRT) Early Norovirus Infant Data Hint At A Broader Oral Vaccine Platform Advantage? - simplywall.st
Vaxart, Inc. Leads Six-Month Stock Returns with 59.48% Gain - Markets Mojo
Vaxart (NASDAQ:VXRT) Upgraded to "Buy" at Wall Street Zen - MarketBeat
Lobbying Update: $50,000 of VAXART INC. lobbying was just disclosed - Quiver Quantitative
The 3 Penny Stocks You Swore You’d Never Buy (But You’ll Check Anyway) - MarketBeat
Vaxart (VXRT) Advances Oral Vaccine with Promising Phase 1 Trial Results - GuruFocus
Vaxart Publishes Positive Phase 1 Trial Results for Oral Norovirus Vaccine in Breastfeeding Women, Highlighting Passive Immunity Transfer to Infants - Quiver Quantitative
Vaxart Publishes Positive Data for its Oral Bivalent Norovirus Candidate in Lactating Women and Their Infants - Yahoo Finance
Vaxart secures $105.9 million more for COVID-19 pill vaccine trial - MSN
Vaxart’s Oral Vaccine Bet Hits A Funding Wall - Finimize
Can Celldex Therapeutics Inc disrupt its industry2025 Geopolitical Influence & Reliable Price Action Trade Plans - baoquankhu1.vn
Is Vaxart Inc. stock supported by strong fundamentalsJuly 2025 Trade Ideas & AI Driven Price Predictions - Улправда
Will Vaxart Inc. stock outperform international peersMarket Trend Review & Technical Pattern Recognition Alerts - Улправда
Vaxart to Participate in the Global BioInnovation Forum on January 13, 2026 - The Manila Times
Aug Sentiment: How geopolitical tensions affect Vaxart Inc. stockQuarterly Portfolio Summary & Fast Entry Momentum Trade Alerts - ulpravda.ru
Why Vaxart Inc. (NB11) stock attracts wealthy investorsEarnings Growth Patterns & Superior Capital Growth - ulpravda.ru
Vaxart Inc Stock Analysis and ForecastVolume Spike Alerts & Free Stock Index Interpretations - Early Times
Vaxart Provides Business Update and Reports Third Quarter 2025 Financial Results - ADVFN
Moving Averages: What valuation ratios show for Vaxart Inc NB11 stock2025 AllTime Highs & Daily Oversold Stock Bounce Ideas - Bộ Nội Vụ
VAXART, INC. (VXRT) Reports Q2 Loss, Beats Revenue Estimates - MSN
Vaxart Q3 2025 Earnings Preview - MSN
Vaxart to relocate headquarters amid lease termination - MSN
Vaxart to Relocate Headquarters Amid Lease Termination - The Globe and Mail
Vaxart to terminate headquarters lease early, plans relocation in South San Francisco - Investing.com Nigeria
Vaxart (VXRT) terminates South San Francisco HQ lease and plans relocation - Stock Titan
Vaxart (NASDAQ:VXRT) Shares Cross Below 200-Day Moving AverageTime to Sell? - MarketBeat
Will Vaxart Inc. stock outperform tech sector in 2025July 2025 Action & Weekly Setup with ROI Potential - Улправда
Will Vaxart Inc. stock benefit from automationJuly 2025 Sentiment & Daily Stock Trend Watchlist - Улправда
Why Vaxart Inc. (NB11) stock fits value portfolios2025 Volatility Report & Growth Oriented Trade Recommendations - Улправда
Is Vaxart Inc. stock undervalued vs historical averagesWatch List & Community Consensus Picks - Улправда
Is Vaxart Inc. stock in correction or buying zoneJuly 2025 Opening Moves & Weekly Stock Breakout Alerts - DonanımHaber
Why Vaxart Inc. stock is seen as undervaluedBond Market & Daily Entry Point Trade Alerts - Улправда
Sell Signal: Why Vaxart Inc. (NB11) stock attracts wealthy investorsJuly 2025 Weekly Recap & Daily Entry Point Alerts - ulpravda.ru
Vaxart (NASDAQ:VXRT) Stock Price Passes Below 200 Day Moving AverageHere's Why - MarketBeat
Chipmakers Recap: How sustainable is Vaxart Inc stock dividend payoutJuly 2025 Trends & Free Community Consensus Stock Picks - Bộ Nội Vụ
Vaxart (NASDAQ:VXRT) Stock Passes Below 200-Day Moving AverageShould You Sell? - MarketBeat
CEO Lo Acquires 97,198 Of Vaxart Inc [VXRT] - TradingView — Track All Markets
Shareholder Finney Files To Sell 40,000 Of Vaxart Inc [VXRT] - TradingView — Track All Markets
Vaxart Inc (VXRT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.96%
2.92%
자본화:
|
볼륨(24시간):